ENSERVCO CORP (ENSV)

US29358Y2019 - Common Stock

0.1452  +0 (+0.14%)

Fundamental Rating

1

ENSV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 59 industry peers in the Energy Equipment & Services industry. ENSV may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ENSV is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year ENSV has reported negative net income.
ENSV had a positive operating cash flow in the past year.
In the past 5 years ENSV always reported negative net income.
ENSV had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

ENSV's Return On Assets of -56.39% is on the low side compared to the rest of the industry. ENSV is outperformed by 98.36% of its industry peers.
Looking at the Return On Equity, with a value of -437.54%, ENSV is doing worse than 93.44% of the companies in the same industry.
Industry RankSector Rank
ROA -56.39%
ROE -437.54%
ROIC N/A
ROA(3y)-40.51%
ROA(5y)-29.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 17.70%, ENSV is doing worse than 73.77% of the companies in the same industry.
In the last couple of years the Gross Margin of ENSV has declined.
ENSV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.75%

0

2. Health

2.1 Basic Checks

ENSV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ENSV has been increased compared to 1 year ago.
Compared to 5 years ago, ENSV has more shares outstanding
Compared to 1 year ago, ENSV has a worse debt to assets ratio.

2.2 Solvency

ENSV has an Altman-Z score of -4.73. This is a bad value and indicates that ENSV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ENSV (-4.73) is worse than 90.16% of its industry peers.
The Debt to FCF ratio of ENSV is 17.31, which is on the high side as it means it would take ENSV, 17.31 years of fcf income to pay off all of its debts.
ENSV has a Debt to FCF ratio of 17.31. This is in the lower half of the industry: ENSV underperforms 62.30% of its industry peers.
ENSV has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.08, ENSV is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 17.31
Altman-Z -4.73
ROIC/WACCN/A
WACC12.29%

2.3 Liquidity

ENSV has a Current Ratio of 0.99. This is a bad value and indicates that ENSV is not financially healthy enough and could expect problems in meeting its short term obligations.
ENSV's Current ratio of 0.99 is on the low side compared to the rest of the industry. ENSV is outperformed by 95.08% of its industry peers.
ENSV has a Quick Ratio of 0.99. This is a bad value and indicates that ENSV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.96, ENSV is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.96

5

3. Growth

3.1 Past

ENSV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.36%, which is quite impressive.
The Revenue has been growing slightly by 3.26% in the past year.
ENSV shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.40% yearly.
EPS 1Y (TTM)58.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)3.26%
Revenue growth 3Y12.05%
Revenue growth 5Y-12.4%
Sales Q2Q%0.94%

3.2 Future

ENSV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.37% yearly.
Based on estimates for the next years, ENSV will show a very strong growth in Revenue. The Revenue will grow by 25.68% on average per year.
EPS Next Y64.92%
EPS Next 2Y35.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.02%
Revenue Next 2Y25.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ENSV. In the last year negative earnings were reported.
Also next year ENSV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

ENSV's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 24.56
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ENSV's earnings are expected to grow with 35.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.37%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ENSV!.
Industry RankSector Rank
Dividend Yield N/A

ENSERVCO CORP

NYSEARCA:ENSV (11/1/2024, 8:04:00 PM)

0.1452

+0 (+0.14%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-14 2024-08-14/amc
Earnings (Next)11-13 2024-11-13/amc
Inst Owners3.78%
Inst Owner Change13.38%
Ins Owners56.46%
Ins Owner Change2.61%
Market Cap6.66M
Analysts82.5
Price Target5.1 (3412.4%)
Short Float %0.17%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)143.88%
Min EPS beat(2)14.75%
Max EPS beat(2)273.01%
EPS beat(4)2
Avg EPS beat(4)54.65%
Min EPS beat(4)-50.06%
Max EPS beat(4)273.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.75%
Min Revenue beat(2)-4%
Max Revenue beat(2)2.51%
Revenue beat(4)1
Avg Revenue beat(4)-5.13%
Min Revenue beat(4)-15.31%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF 24.56
P/OCF 10.35
P/B 4.45
P/tB 4.74
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.01
FCFY4.07%
OCF(TTM)0.01
OCFY9.66%
SpS0.5
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.39%
ROE -437.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.7%
FCFM 1.18%
ROA(3y)-40.51%
ROA(5y)-29.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.75%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 17.31
Debt/EBITDA N/A
Cap/Depr 13.33%
Cap/Sales 1.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.96
Altman-Z -4.73
F-Score6
WACC12.29%
ROIC/WACCN/A
Cap/Depr(3y)7.9%
Cap/Depr(5y)10.29%
Cap/Sales(3y)2.03%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y64.92%
EPS Next 2Y35.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.26%
Revenue growth 3Y12.05%
Revenue growth 5Y-12.4%
Sales Q2Q%0.94%
Revenue Next Year33.02%
Revenue Next 2Y25.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y146.26%
OCF growth 3YN/A
OCF growth 5YN/A